Asthma Medications During Pregnancy: New Perspectives

This course is part of the 2017 Virtual Annual Meeting. Want more virtual meeting recordings? Save by ordering the full set!

Session 2811 from the 2017 AAAAI Annual Meeting will describe the CDC's Treating for Two Initiative and how it can help allergists provide care and information to pregnant women,  present recent results from VAMPSS regarding the effects of asthma severity and control on pregnancy outcomes.

AMA PRA Category 1 Credits™: 1.25
CE: 1.25

 

Target Audience

Physicians
Allergists/Immunologists
Nurses
Nurse Practitioners
Allied Health Professionals

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Appreciate how the CDC Treating for Two Initiative can help health care providers and patients identify the safest treatment options for the management of common conditions before and during pregnancy
  • Identify the effects of severe or uncontrolled asthma on pregnancy outcomes
  • Describe the application of these concepts to the care of pregnant asthmatic patients for optimal outcomes
Summary
Available credit: 
  • 1.25 Attendance
    Attendance credit.
  • 1.25 CE
    CE credit.
  • 1.25 CME
    CME credit.
Course opens: 
05/31/2017
Course expires: 
06/14/2019
Cost:
$25.00
Part of: 
Asthma - 2017 Virtual Annual Meeting Recordings
Rating: 
0

Faculty
Dr. Kristin Palmsten, ScD
University of California - San Diego, San Diego, CA
Relevant relationships: None

 

Carla Van Bennekom, BSN MPH
Boston University, Boston, MA
Relevant relationships: None

 

Reviewers
Jon Ramsey, RN
Georgia Asthma Coalition, Albany, GA
Relevant relationships: Genentech: speaker (Xolair); Shire/Baxalta: advisory board

Kristin Sokol, MD
Beth Israel Deaconess Medical Center, Brookline, MA
Relevant relationships: None

Disclosure link: 
2017 Annual Meeting Planning, Review and Faculty Disclosures

Accreditation Statement
The American Academy of Allergy, Asthma and Immunology (AAAAI) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement
The American Academy of Allergy, Asthma & Immunology designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CE Designation Statement
The American Academy of Allergy, Asthma, & Immunology (AAAAI) is a Provider, approved by the California Board of Registered Nursing, Provider #10704, for up to 1.25 Contact Hours.

Medium and Method of Physician Participation for an Enduring Activity
Follow these steps to complete the activity:

  1. Register for the activity.
  2. Review the CME and Disclosure information.
  3. Complete all required components.
  4. Complete the post-test. You must achieve a score of 70% or higher on post-tests to claim credit.
  5. Complete the activity evaluation.
  6. Claim your credits. Enter only the number of credits earned based on your participation in the activity.
  7. Print or save your certificate.

AAAAI Privacy Policy
To verify your participation in educational activities, you may be asked to provide your name, contact information, and/or other descriptors. The AAAAI will not release this information to outside entities. It may be used internally to inform you of other AAAAI educational activities. If you wish to have your information excluded from this process, please contact us at cme@aaaai.org.

Release date
Original release date: June 1, 2017.  Valid for credit through May 31, 2019.

Questions
Activity-related questions should be directed to cme@aaaai.org

Available Credit

  • 1.25 Attendance
    Attendance credit.
  • 1.25 CE
    CE credit.
  • 1.25 CME
    CME credit.

Price

Cost:
$25.00
Please login or register to take this course.